Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on December 22, 2004
J Am Soc Nephrol 16: 352-362, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004070568

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004070568v1
16/2/352    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, Y.-S.
Right arrow Articles by Natarajan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, Y.-S.
Right arrow Articles by Natarajan, R.

Cell Biology

Novel Interactions between TGF-{beta}1 Actions and the 12/15-Lipoxygenase Pathway in Mesangial Cells

Young-Sook Kim*, Zhong-Gao Xu*, Marpadga A. Reddy*, Shu-Lian Li*, Linda Lanting*, Kumar Sharma{dagger}, Sharon G. Adler{ddagger} and Rama Natarajan*

* Gonda Diabetes Research Center, Beckman Research Institute of the City of Hope, Duarte, California; {dagger} Division of Nephrology, Dorrance Hamilton Research Laboratories, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania; and {ddagger} Division of Nephrology and Hypertension, Department of Internal Medicine, Harbor-UCLA Research and Education Institute, Torrance, California

Address correspondence to: Dr. Rama Natarajan, Gonda Diabetes Research Center, Beckman Research Institute of the City of Hope, 1500 East Duarte Road, Duarte, CA 91010. Phone: 626-359-8111, ext 62289; Fax: 626-301-8136; rnatarajan{at}coh.org

Diabetic nephropathy (DN) is characterized by mesangial cell (MC) hypertrophy and progressive accumulation of glomerular extracellular matrix (ECM). It was reported recently that 12/15-lipoxygenase (12/15-LO) expression is increased in high-glucose (HG)–stimulated MC and in experimental DN. 12-LO products could also directly induce MC hypertrophy and ECM expression and mediate growth factor effects, thus implicating the 12/15-LO pathway in DN. Because TGF-{beta} is a major player in the pathogenesis of DN, whether there is an interplay between the TGF-{beta} and 12/15-LO pathways in MC was evaluated. Treatment of rat MC (RMC) with TGF-{beta} significantly increased levels of the 12/15-LO product 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] and also 12/15-LO mRNA and protein expression. HG-induced TGF-{beta} mRNA expression in RMC was inhibited by a specific ribozyme and siRNA targeted to knockdown rat 12/15-LO. It is interesting that direct treatment of RMC with 12(S)-HETE increased TGF-{beta} mRNA and protein levels, as well as p-Smad2/3, which are TGF-{beta}–specific target transcription factors. 12(S)-HETE also increased transcription from a minimal TGF-{beta} promoter. Furthermore, TGF-{beta} expression and p-Smad2/3 levels were lower in MC from 12/15-LO knockout mice relative to control mice. Reciprocally, mouse MC stably overexpressing 12/15-LO had greater TGF-{beta} mRNA and also nuclear p-Smad2/3 relative to mock-transfected cells. 12/15-LO and TGF-{beta} could functionally signal and increase ECM expression via the p38 mitogen-activated protein kinase signaling pathway. These results indicate for the first time that the 12/15-LO and TGF-{beta} pathways can cross-talk and activate each other. These novel interactions may amplify the signal transduction cascades and molecular events that lead to DN.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
Z.-G. Xu, L.-N. Miao, Y.-C. Cui, Y. Jia, H. Yuan, and M. Wu
Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose stimulated glomerular cells and type 2 diabetic glomeruli
Nephrol. Dial. Transplant., December 22, 2008; (2008) gfn703v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. M. Abdel-Rahman, P. M. Abadir, and H. M. Siragy
Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1473 - R1478.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Yuan, L. Lanting, Z.-G. Xu, S.-L. Li, P. Swiderski, S. Putta, M. Jonnalagadda, M. Kato, and R. Natarajan
Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F605 - F617.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Z.-G. Xu, H. Yuan, L. Lanting, S.-L. Li, M. Wang, N. Shanmugam, M. Kato, S. G. Adler, M. A. Reddy, and R. Natarajan
Products of 12/15-Lipoxygenase Upregulate the Angiotensin II Receptor
J. Am. Soc. Nephrol., March 1, 2008; 19(3): 559 - 569.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Guha, Z.-G. Xu, D. Tung, L. Lanting, and R. Natarajan
Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes
FASEB J, October 1, 2007; 21(12): 3355 - 3368.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. G. Obrosova, O. Ilnytska, V. V. Lyzogubov, I. A. Pavlov, N. Mashtalir, J. L. Nadler, and V. R. Drel
High-Fat Diet Induced Neuropathy of Pre-Diabetes and Obesity: Effects of "Healthy" Diet and Aldose Reductase Inhibition
Diabetes, October 1, 2007; 56(10): 2598 - 2608.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kato, J. Zhang, M. Wang, L. Lanting, H. Yuan, J. J. Rossi, and R. Natarajan
MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors
PNAS, February 27, 2007; 104(9): 3432 - 3437.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Kato, H. Yuan, Z.-G. Xu, L. Lanting, S.-L. Li, M. Wang, M. C.-T. Hu, M. A. Reddy, and R. Natarajan
Role of the Akt/FoxO3a Pathway in TGF-beta1-Mediated Mesangial Cell Dysfunction: A Novel Mechanism Related to Diabetic Kidney Disease
J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3325 - 3335.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. Cheng, M. M. D. Encarnacion, G. M. Warner, C. E. Gray, K. A. Nath, and J. P. Grande
TGF-{beta}1 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process
Am J Physiol Cell Physiol, October 1, 2005; 289(4): C959 - C970.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP